Neurocrine Biosciences
NBIX
#1636
Rank
HK$102.90 B
Marketcap
HK$1,032
Share price
-0.72%
Change (1 day)
-7.45%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Market capitalization of Neurocrine Biosciences (NBIX)

Market cap: HK$102.90 Billion

As of January 2026 Neurocrine Biosciences has a market cap of HK$102.90 Billion. This makes Neurocrine Biosciences the world's 1636th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Neurocrine Biosciences from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$102.90 B-8.68%
2025HK$112.68 B2.81%
2024HK$109.60 B8.4%
2023HK$101.10 B12.7%
2022HK$89.71 B42.4%
2021HK$63.00 B-9.25%
2020HK$69.42 B-10.13%
2019HK$77.24 B52.13%
2018HK$50.77 B-5.35%
2017HK$53.64 B105.77%
2016HK$26.07 B-31.07%
2015HK$37.82 B185.45%
2014HK$13.24 B171.63%
2013HK$4.87 B26.62%
2012HK$3.85 B5.61%
2011HK$3.64 B11.8%
2010HK$3.26 B251.71%
2009HK$0.92 B-2.79%
2008HK$0.95 B-29.55%
2007HK$1.35 B-55.9%
2006HK$3.07 B-82.99%
2005HK$18.05 B29.03%
2004HK$13.99 B-6.24%
2003HK$14.92 B36.73%
2002HK$10.91 B-10.08%
2001HK$12.14 B85.66%
2000HK$6.54 B57.41%
1999HK$4.15 B312.03%
1998HK$1.00 B-6.58%
1997HK$1.07 B-24.03%
1996HK$1.42 B

End of Day market cap according to different sources

On Jan 17th, 2026 the market cap of Neurocrine Biosciences was reported to be:

HK$102.90 Billion
by Nasdaq info icon info icon
HK$102.90 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Repligen
RGEN
HK$71.10 B-30.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
HK$179.80 B 74.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Palatin Technologies
PTN
HK$0.23 B-99.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$7.257 T 6,952.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$2.953 T 2,769.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.136 T 1,004.83%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
HK$14.85 B-85.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$6.49 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA